- Home
- NVCR vs PGRE Comparison
NVCR vs PGRE Comparison
Compare NVCR & PGRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- PGRE
- Stock Information
- Founded
- NVCR 2000
- PGRE 1978
- Country
- NVCR Switzerland
- PGRE United States
- Employees
- NVCR N/A
- PGRE N/A
- Industry
- NVCR Medical/Dental Instruments
- PGRE Real Estate Investment Trusts
- Sector
- NVCR Health Care
- PGRE Real Estate
- Exchange
- NVCR Nasdaq
- PGRE Nasdaq
- Market Cap
- NVCR 1.4B
- PGRE 1.4B
- IPO Year
- NVCR 2015
- PGRE 2014
- Fundamental
- Price
- NVCR $11.32
- PGRE $6.07
- Analyst Decision
- NVCR Buy
- PGRE Hold
- Analyst Count
- NVCR 7
- PGRE 4
- Target Price
- NVCR $28.79
- PGRE $5.63
- AVG Volume (30 Days)
- NVCR 1.7M
- PGRE 2.9M
- Earning Date
- NVCR 07-24-2025
- PGRE 07-30-2025
- Dividend Yield
- NVCR N/A
- PGRE N/A
- EPS Growth
- NVCR N/A
- PGRE N/A
- EPS
- NVCR N/A
- PGRE N/A
- Revenue
- NVCR $630,160,000.00
- PGRE $701,980,000.00
- Revenue This Year
- NVCR $6.15
- PGRE $1.41
- Revenue Next Year
- NVCR $7.35
- PGRE N/A
- P/E Ratio
- NVCR N/A
- PGRE N/A
- Revenue Growth
- NVCR 14.58
- PGRE 35.23
- 52 Week Low
- NVCR $10.91
- PGRE $3.75
- 52 Week High
- NVCR $34.13
- PGRE $6.89
- Technical
- Relative Strength Index (RSI)
- NVCR 25.05
- PGRE 42.87
- Support Level
- NVCR $10.91
- PGRE $5.75
- Resistance Level
- NVCR $12.38
- PGRE $6.42
- Average True Range (ATR)
- NVCR 0.93
- PGRE 0.21
- MACD
- NVCR -0.49
- PGRE -0.07
- Stochastic Oscillator
- NVCR 6.13
- PGRE 27.63
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About PGRE Paramount Group Inc.
Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district (CBD) submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. The company derives nearly all of its majority of revenue from rental income.